Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Enhabit, Inc. Director's Dealing 2022

Aug 10, 2022

33022_dirs_2022-08-10_415c2533-e20f-4864-81cb-e9282614ed60.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enhabit, Inc. (EHAB)
CIK: 0001803737
Period of Report: 2022-08-09

Reporting Person: SHAW L EDWARD JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-09 Common Stock P 10000 $13.64 Acquired 28989 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.32 to $13.80, inclusive. The reporting person undertakes to provide to Enhabit, Inc., any security holder of Enhabit, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: The amount of shares of common stock reported in Column 5 is less than previously reported due to the way Encompass Health Corporation restricted stock units were treated in the separation and distribution from Encompass Health Corporation.